City of Hope and Adagene Launch Clinical Trial for Advanced Colorectal Cancer Therapy
3 Articles
3 Articles
City of Hope and Adagene launch clinical trial for advanced colorectal cancer therapy
City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States, and Adagene Inc., a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, today announced the launch of an innovative Phase 1 clinical trial to explore a new combination therapy for patients battling metastatic colorectal cancer, particularly for those w…
Adagene and City of Hope Open Clinical Trial to Test New Therapy for Patients with Hard-to-Treat Colorectal Cancer
Study designed by medical oncologist to accelerate lifesaving care to patients SAN DIEGO and LOS ANGELES, Nov. 17, 2026 (GLOBE NEWSWIRE) — Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, and City of Hope, one of the largest and most advanced cancer research and […]
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium







